Inventor

ERIKSEN BIRGITTE L

DK20 patents

⚠️ This page may combine multiple inventors who share the name “ERIKSEN BIRGITTE L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ERIKSEN BIRGITTE L

NEUROSEARCH AS

Purinyl derivatives and their use as potassium channel modulators

Purinyl derivatives and their use as potassium channel modulators

Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors

Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Guanidine derivatives and their medical use

3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

2-aminio-pyridine derivatives and their use as potassium channel modulators

3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

ERIKSEN BIRGITTE L

Pyrazine derivatives and their use as potassium channel modulators

Potassium channel modulating agents and their medical use

Indazolyl derivatives useful as potassium channel modulating agents

Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators

Substituted purinyl-pyrazole derivatives and their use as potassium channel modulators

3-aza spiro[5,5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

PETERS DAN

8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

SOERENSEN ULRIK SVANE

Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators

SØRENSEN ULRIK SVANE

Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators